Missing: OrthAlign's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: OrthAlign's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing OrthAlign
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
OrthAlign is included in 3 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
OrthAlign has filed 45 patents.
Orthopedic surgical procedures, Prosthetics, Implants (medicine), Surgical instruments, Arthritis
Orthopedic surgical procedures, Prosthetics, Implants (medicine), Surgical instruments, Arthritis
Latest OrthAlign News
Dec 5, 2022
News provided by Share this article Share this article NEW YORK, Dec. 5, 2022 /PRNewswire/ -- OrthAlign, Inc., a pioneering medical device company that provides orthopedic surgeons with advanced precision computer-assisted technology, is celebrating the 16,500th procedure at Hospital for Special Surgery (HSS) with 25 of its surgeons using its technology in hip and knee replacements. OrthAlign® is a handheld navigation device that allows for accurate component positioning for total and partial knee and total hip arthroplasty. The next generation platform weighs only 7 ounces and is designed to improve results through simple workflows. It is more efficient and cost effective than previous surgical technologies, as it can be used without the financial investment, pre-operative imaging, or processes required by many robotic or computer-assisted surgical systems. "This is another great milestone for our organization, says Eric Timko, Chairman and CEO of OrthAlign, Inc. "Technology in every room and in every case is the future; OrthAlign is the catalyst to make that happen." OrthAlign consists of one single-use disposable unit and one tray per patient case. This meets the needs of multiple operating rooms, increasing the number of surgeries that can be performed per facility. In addition, it shortens operating room time and reduces the cost to surgeons and patients. It is run on an Android system and is compatible with standard implant systems. "Using OrthAlign technology allows me to accurately execute my cuts in TKA. The system is simple, and it allows me to have the freedom to adjust my game plan intraoperatively," says orthopedic surgeon Dr. Cynthia Kahlenberg. "Without a lot of extra work or planning, I can get all the important information out of the system – perfect alignment and reliability." says Dr. Mike Ast, an orthopedic surgeon. Dr. Michael Parks, orthopedic surgeon, says, "using OrthAlign provides me added confidence in the accuracy of the cuts I perform in TKA. This is especially useful in patients with difficult anatomy and in obese patients to ensure satisfactory placement of the knee components." Dr. Brian Chalmers, also an orthopedic surgeon, adds "OrthAlign navigation gives me the control and confidence to set individualized alignment targets for different patients to optimize their soft tissue balance and outcomes." The handheld navigation technology is currently being used in hospitals and surgical facilities across the country. In November of 2021 the company launched Lantern®, its newest technology, which builds upon the clinical success of OrthAlign; it has since become the company's flagship product. It provides orthopedic surgeons with a state-of-the-art device for improving outcomes of total and partial knee replacement surgery. Timko says he is excited to reach this milestone with HSS, which is consistently ranked Number 1 in orthopedics nationwide by U.S. News & World Report and worldwide by Newsweek, and has facilities in New York, New Jersey, Connecticut, and Florida. He looks forward to more milestones in the future. "We are committed to making empowering technologies accessible to all. We believe the future is bright." OrthAlign, Inc., is a privately held U.S.-based medical device company that provides orthopedic surgeons with advanced precision computer-assisted technologies designed to deliver healthier and more pain-free lifestyles to joint replacement patients. Driven by the belief that everyone deserves exceptional healthcare, we are committed to making empowering technologies accessible to all. For more information regarding OrthAlign, please visit www.orthalign.com . "ORTHALIGN®, ORTHALIGN PLUS®, LANTERN®, KNEEALIGN®, HIPALIGN® and UNIALIGN®" are registered trademarks of OrthAlign, Inc. SOURCE OrthAlign
OrthAlign Frequently Asked Questions (FAQ)
When was OrthAlign founded?
OrthAlign was founded in 2008.
Where is OrthAlign's headquarters?
OrthAlign's headquarters is located at 120 Columbia, Aliso Viejo.
What is OrthAlign's latest funding round?
OrthAlign's latest funding round is Series E - II.
How much did OrthAlign raise?
OrthAlign raised a total of $57.3M.
Who are the investors of OrthAlign?
Investors of OrthAlign include RC Capital, Mutual Capital Partners, California Technology Ventures, Paycheck Protection Program, Research Corporation Technologies and 6 more.
Who are OrthAlign's competitors?
Competitors of OrthAlign include Dune Medical Devices, ArthroSurface, Avantis Medical Systems, Zyga Technology, Entellus Medical, Freedom Innovations, SonarMed, CoolSculpting, Cayenne Medical, Cohera Medical and 25 more.
Compare OrthAlign to Competitors
Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.
CSA Medical is a developer of cryospray therapy platforms, truFreeze, and Rejuvenair.
Freedom Innovations is a high technology provider of premium prosthetic devices, a growing segment of the non-invasive orthopedic market. It deals with making prosthetic devices with latest technological developments and customization for lower limb amputations. The branded carbon fiber foot products lead the industry in reputation and growth rate. The company's first microprocessor-controlled product, the Pli' MPC Knee, was introduced in May 2007, serving as an entry into the SMART technology arena.What aims to make the company and the products is the high customization in the prosthetic devices market ranging from different limbs for swimmers to bikers to soldiers and so on. In February 2012, Health Evolution Partners acquired a majority stake in Freedom Innovations. The valuation of Freedom Innovations was undisclosed. Other terms of the deal were not released.
Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.
Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.
NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.